Interaction between antihypertensives and NSAIDs in primary care: A controlled trial
Main Article Content
Keywords
antihypertensives, NSAIDs, primary care
Abstract
High blood pressure is the leading risk for death in the world.1 In North American society it is estimated that over 90% of adults will develop hypertension if they live an average life span.2 Lowering blood pressure with antihypertensive therapy can reverse much of the risk associated with hypertension.3 Nevertheless, even in developed countries poor blood pressure control is the norm rather than the exception
References
2. Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D'Agostino RB, et al. Residual lifetime risk for developing hypertension in middle-aged women and men. JAMA. 2002;287:1003-10.
3. Smith SC Jr, Blair SN, Criqui MH, Fletcher GF, Fuster V, Gersh BJ, et al. Preventing heart attack and death in patients with coronary disease. Circulation. 1995;92:2-4.
4. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense H-W, Joffres M, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003;289:236369.
5. Hogan DB, Campbell NRC, Crutcher R, Jennett P, MacLeod N. Prescription of nonsteroidal anti-inflammatory drugs for elderly people in Alberta. CMAJ 1994;151:315-22.
6. Gyamlani G, Geraci SA. Secondary hypertension due to drugs and toxins. South Med J 2007;100:692-99.
7. Culleton BF, McKay DW, Campbell NR. Performance of the automated BpTRU measurement device in the assessment of white-coat hypertension and white-coat effect. Blood Press Monit 2006;11:37-42.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.